Related Experiment Video
Updated: Aug 2, 2026
06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
MalignancyCase Report: Systemic Sarcoidosis Preceeding Acute Myeloid Leukemia
CAROL Alliot1, MARTA Barrios, FRÉDÉRIC Franck
1General Hospital, Avenue du Docteur Roullet, 19208 Ussel Cedex.
Hematology (Amsterdam, Netherlands)
|June 16, 2001
Summary
A woman developed acute myeloid leukemia after sarcoidosis treatment. This rare case explores potential links between granulomatous reactions, cytokines, or infection and leukemia development.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Systemic sarcoidosis is an inflammatory condition characterized by granuloma formation.
- Corticosteroid therapy is a common treatment for sarcoidosis.
- Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow.
Purpose of the Study:
- To report a rare case of acute myeloid leukemia (AML) following systemic sarcoidosis.
- To investigate potential physiopathogenic mechanisms linking sarcoidosis and AML.
- To explore the role of granulomatous reactions, cytokines, or infectious agents in AML development post-sarcoidosis.
Main Methods:
- Case report of a 59-year-old female patient.
- Review of patient's medical history including sarcoidosis diagnosis and treatment.
- Analysis of temporal relationship between sarcoidosis resolution and AML onset.
Main Results:
- The patient developed acute myeloid leukemia nine months after sarcoidosis resolution.
- The case presents a rare occurrence of AML following treated systemic sarcoidosis.
Conclusions:
- The development of AML after sarcoidosis warrants further investigation into underlying mechanisms.
- Potential links include granulomatous reactions to leukemic antigens or cytokines, or an underlying infectious etiology.
- This case highlights the need to consider complex interactions between inflammatory diseases, treatments, and secondary malignancies.
